Kim Jong-Tae, Cho Hee Jun, Park Sang Yoon, Oh Byung Moo, Hwang Yo Sep, Baek Kyoung Eun, Lee Young-Ha, Kim Hee Cheol, Lee Hee Gu
Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
Department of Biomolecular Science, University of Science and Technology (UST), Daejeon, Republic of Korea.
J Cancer. 2019 Oct 15;10(24):6142-6153. doi: 10.7150/jca.32339. eCollection 2019.
DNA replication and sister chromatid cohesion 1 (DSCC1) combines with chromosome transmission-fidelity protein 18 (CTF18) to form a CTF18-DSCC1-CTF8 (CTF18-1-8) module, which in combination with CTF18-replication factor C (RFC) acts as a proliferating cell nuclear antigen (PCNA) loader during DNA replication-associated processes. It was found that DSCC1 was overexpressed in tumor tissues from patients with colon cancer and that the survival probability of patients with colon cancer was lower when the expression of cytosolic DSCC1 was higher in tumor regions (P=0.047). By using DSCC1- or CTF18-knockdown cell lines (HCT116-shDSCC1 or HCT116-shCTF18, respectively), it was confirmed that DSCC1-knockdown inhibits cell proliferation and invasion, but that CTF18-knockdown does not. Tumors in mice xenografted with shDSCC1 cells were significantly smaller compared with those in mice in the mock group or those xenografted with shCTF18 cells. The shDSCC1 cells were highly sensitive to γ-irradiation and other DNA replication inhibitory treatments, resulting in low cell viability. The present results suggested that DSCC1 is the most important component in the CTF18-1-8 module for CTF18-RFC and is highly relevant to the growth and metastasis of colon cancer cells, and, therefore, it may be a potential therapeutic target for colon cancer treatment.
DNA复制与姐妹染色单体黏连蛋白1(DSCC1)与染色体传递保真蛋白18(CTF18)结合形成CTF18-DSCC1-CTF8(CTF18-1-8)模块,该模块与CTF18-复制因子C(RFC)在DNA复制相关过程中作为增殖细胞核抗原(PCNA)加载器发挥作用。研究发现,DSCC1在结肠癌患者的肿瘤组织中过表达,且肿瘤区域胞质DSCC1表达较高时,结肠癌患者的生存概率较低(P = 0.047)。通过使用DSCC1或CTF18敲低细胞系(分别为HCT116-shDSCC1或HCT116-shCTF18),证实DSCC1敲低可抑制细胞增殖和侵袭,但CTF18敲低则无此作用。与模拟组小鼠或接种shCTF18细胞的小鼠相比,接种shDSCC1细胞的小鼠体内肿瘤明显更小。shDSCC1细胞对γ射线照射和其他DNA复制抑制处理高度敏感,导致细胞活力较低。目前的结果表明,DSCC1是CTF18-RFC的CTF18-1-8模块中最重要的组成部分,与结肠癌细胞的生长和转移高度相关,因此,它可能是结肠癌治疗的潜在靶点。